Abbott Reports Second-Quarter 2023 Results; Increases Outlook For Underlying Base Business

Sales of $10.0 billion driven by strong underlying base business performance Reported sales decreased 11.4 percent due to anticipated decline in COVID-19 testing-related sales versus prior year Organic sales growth for underlying base business of 11.5 percent, led by Medical Devices,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.